Delaware
|
001-15697
|
22-3542636
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
Item
1.01
|
Entry
into a Material Definitive Agreement
|
|
Item
3.02
|
Unregistered
Sale of Equity Securities
|
|
Item
3.03
|
Material
Modification to Rights of Security Holders
|
|
Item
5.03
|
Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal
Year
|
|
Item
8.01
|
Other
Events
|
|
·
|
Dividends: The
Series D Preferred Stock will continue to accrue dividends at the rate of
8% per annum on their stated value of US$1,000 per share, payable
quarterly on January 1, April 1, July 1 and October 1 and such rate shall
not increase to 15% per annum as previously provided prior to giving
effect to the Series D Amendment Agreement. In addition to
being payable in cash and shares of Common Stock, as provided in the
Series D Certificate, such dividends may also be paid in shares of Series
D Preferred Stock (the “Dividend Payment
Preferred Stock”) or a combination of cash, Common Stock and
Dividend Payment Preferred Stock. Dividend Payment Preferred
Stock will have the same rights, privileges and preferences as the Series
D Preferred Stock, except that such Dividend Payment Preferred Stock will
not be entitled to, nor accrue, any dividends pursuant to the Amended
Series D Certificate.
|
|
·
|
Conversion
Price: The conversion price of the Series D Preferred
Stock shall be reduced from US$0.20 per share to US$0.07 per share
(subject to adjustment as provided in the Amended Series D
Certificate).
|
|
·
|
Automatic Monthly
Conversion: On each Monthly Conversion Date (as defined
below), a number of shares of Series D Preferred Stock equal to each
holder’s pro-rata portion (based on the shares of Series D Preferred Stock
held by each Holder on June 25, 2010) of the Monthly Conversion Amount (as
defined below) will automatically convert into shares of Common Stock at
the then-effective conversion price (each such conversion, a “Monthly
Conversion”). Notwithstanding the foregoing, the Company
will not be permitted to effect a Monthly Conversion on a Monthly
Conversion Date unless (i) the Common Stock shall be listed or quoted for
trading on a trading market, (ii) there is a sufficient number of
authorized shares of Common Stock for issuance of all Common Stock to be
issued upon such Monthly Conversion, (iii) as to any holder of Series D
Preferred Stock, the issuance of the shares will not cause a breach of the
beneficial ownership limitations set forth in the Amended Series D
Certificate, (iv) if requested by a holder of Series D Preferred Stock and
a customary Rule 144 representation letter relating to all shares of
Common Stock to be issued upon each Monthly Conversion is provided by such
holder after request from the Company, the shares of Common Stock issued
upon such Monthly Conversion are delivered electronically through the
Depository Trust Company or another established clearing corporation
performing similar functions (“DTC”), may be
resold by such holder pursuant to an exemption under the Securities Act
and are otherwise free of restrictive legends and trading restrictions on
such Holder, (v) there has been no public
announcement of a pending or proposed Fundamental Transaction or Change of
Control Transaction (as such terms are defined in the Amended Series D
Certificate) that has not been consummated, (vi) the applicable holder of
Series D Preferred Stock is not in possession of any information provided
to such holder by the Company that constitutes material non-public
information, and (vii) the average VWAP (as defined in the Amended
Series D Certificate) for the 20 trading days immediately prior to the
applicable Monthly Conversion Date equals or exceeds the then-effective
conversion price of the Series D Preferred Stock. Shares of the
Series D Preferred Stock issued to the holders of Series D Preferred Stock
as Dividend Payment Preferred Stock shall be the last shares of Series D
Preferred Stock to be subject to Monthly Conversion. As used
herein, the following terms have the following meanings: (i)
“Monthly
Conversion Date” means the first day of each month, commencing on
August 1, 2010, and terminating on the date the Series D Preferred Stock
is no longer outstanding; (ii) “Monthly Conversion
Amount” means an aggregate Stated Value of Series D Preferred Stock
among all Holders that is equal to 25% of aggregate dollar trading volume
of the Common Stock during the 20 trading days immediately prior to the
applicable Monthly Conversion Date (such 20 trading day period, the “Measurement
Period”), increasing to 35% of the aggregate dollar trading volume
during the Measurement Period if the average VWAP during such Measurement
Period equals or exceeds $0.12 (subject to adjustment for forward and
reverse stock splits and the like that occur after June 25, 2010) and
further increasing to 50% of the aggregate dollar trading volume during
such Measurement Period if the average VWAP during such Measurement Period
equals or exceeds $0.16 (subject to adjustment for forward and reverse
stock splits and the like that occur after June 25,
2010).
|
|
·
|
Change of Control
Transaction: Epic and its affiliates were expressly
excluded from any event which would otherwise constitute a “Change of
Control Transaction” due to the acquisition in excess of 40% of the
Company’s voting securities.
|
Item
9.01
|
Financial
Statements and Exhibits
|
|
a)
|
Not
applicable.
|
|
b)
|
Not
applicable.
|
|
c)
|
Not
applicable.
|
|
d)
|
Exhibits
|
Exhibit No.
|
Exhibit Description
|
|
3.1
|
Amended
Certificate of Designations of the Series D 8% Convertible Preferred Stock
as filed with the Secretary of State of the State of Delaware on June 29,
2010
|
|
3.2
|
Amended
Certificate of Designations of the Series E Convertible Preferred Stock as
filed with the Secretary of State of the State of Delaware on June 29,
2010
|
|
10.1
|
Form
of Stipulation of Settlement and Release, dated as of June 25, 2010, by
and among the Company, Midsummer Investment, Ltd., Bushido Capital Master
Fund, LP, BCMF Trustees, LLC, Epic Pharma, LLC and Epic Investments,
LLC
|
|
10.2
|
Form
of Amendment Agreement, dated as of June 25, 2010, by and among the
Company, and the investors signatory thereto
|
|
10.3
|
Form
of Amendment Agreement, dated as of June 2010, by and among the Company,
Epic Pharma, LLC and Epic Investments, LLC
|
|
99.1
|
Press
Release dated June 30, 2010
|
July
1, 2010
|
||
ELITE
PHARMACEUTICALS, INC.
|
||
By:
|
/s/
Jerry Treppel
|
|
|
Jerry
Treppel
|
|
|
Chief
Executive Officer
|